Literature DB >> 8835207

Operative resection of 100 spinal lipomas in infants less than 1 year of age.

R W Byrne1, E A Hayes, T M George, D G McLone.   

Abstract

A retrospective analysis of 100 children followed at Children's Memorial Hospital, Chicago, who underwent surgery for a spinal lipoma was performed. The mean follow-up was 5 years. We found that an operation performed during the 1st year of life with the goal of untethering the spinal cord and debulking the spinal lipoma was safe and effective, whereas a cosmetic (nonuntethering) procedure always led to delayed postoperative deterioration (symptomatic tethered cord). Of the infants that presented with motor, urologic or orthopedic symptoms, 39% improved, 58% stabilized, while 3% worsened as a result of surgery. No asymptomatic infant deteriorated postoperatively and 93% of these children remained symptom-free at follow-up (mean follow-up was 44 months). The overall outcome of infants after untethering procedures in this study was significantly better than the natural history of spinal lipomas. Several risk factors were identified that may predispose children to delayed postoperative deterioration: an initial cosmetic procedure; the presence of preoperative symptoms, and the presence of a lipomyelomeningocele.

Entities:  

Mesh:

Year:  1995        PMID: 8835207     DOI: 10.1159/000120956

Source DB:  PubMed          Journal:  Pediatr Neurosurg        ISSN: 1016-2291            Impact factor:   1.162


  18 in total

1.  Early- and long-term surgical outcomes in 109 children with lipomyelomeningocele.

Authors:  Tarang K Vora; Shabari Girishan; Ranjith K Moorthy; Vedantam Rajshekhar
Journal:  Childs Nerv Syst       Date:  2021-01-06       Impact factor: 1.475

Review 2.  Surgical treatment of complex spinal cord lipomas.

Authors:  Dachling Pang; John Zovickian; Sui-To Wong; Yong Jin Hou; Greg S Moes
Journal:  Childs Nerv Syst       Date:  2013-09       Impact factor: 1.475

Review 3.  Conservative and surgical treatment of pediatric asymptomatic lumbosacral lipoma: a meta-analysis.

Authors:  Yang Xiong; Liu Yang; Wang Zhen; Dong Fangyong; Wan Feng; Lei Ting
Journal:  Neurosurg Rev       Date:  2016-10-28       Impact factor: 3.042

4.  Dynamic morphological changes in lumbosacral lipoma during the first months of life revealed by constructive interference in steady-state (CISS) MR imaging.

Authors:  Takato Morioka; Kimiaki Hashiguchi; Fumiaki Yoshida; Shinji Nagata; Yasushi Miyagi; Futoshi Mihara; Tomio Sasaki
Journal:  Childs Nerv Syst       Date:  2006-12-23       Impact factor: 1.475

5.  Lateral tethering intraspinal lipoma with scoliosis.

Authors:  Bashar Abuzayed; Reza Dashti; Fatma Ozlen; Pamir Erdincler
Journal:  Eur Spine J       Date:  2010-06-29       Impact factor: 3.134

6.  Children with tethered cord syndrome of different etiology benefit from microsurgery-a single institution experience.

Authors:  Pantelis Stavrinou; Mathias Kunz; Markus Lehner; Alfred Heger; Wolfgang Müller-Felber; Joerg-Christian Tonn; Aurelia Peraud
Journal:  Childs Nerv Syst       Date:  2011-01-06       Impact factor: 1.475

7.  Results of the prophylactic surgery of lumbosacral lipomas 20 years of experience in the Paediatric Neurosurgery Department La Timone Enfants Hospital, Marseille, France.

Authors:  Sandra Pérez da Rosa; Didier Scavarda; Maurice Choux
Journal:  Childs Nerv Syst       Date:  2016-08-15       Impact factor: 1.475

8.  Surgery for spinal cord lipomas.

Authors:  Manish K Kasliwal; Ashok K Mahapatra
Journal:  Indian J Pediatr       Date:  2007-04       Impact factor: 1.967

9.  Tethered spinal cord with double spinal lipomas.

Authors:  Myeong Jin Kim; Soo Han Yoon; Ki Hong Cho; Geun Soo Won
Journal:  J Korean Med Sci       Date:  2006-12       Impact factor: 2.153

10.  Symptomatic retethering of the spinal cord in postoperative lipomyelomeningocele patients: a meta-analysis.

Authors:  Dylan J Goodrich; Dipen Patel; Marios Loukas; R Shane Tubbs; W Jerry Oakes
Journal:  Childs Nerv Syst       Date:  2015-08-07       Impact factor: 1.475

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.